Evaluation of outpatient prescription patterns of COVID-19 drugs in Iran: comparison of real practice with local therapeutic recommendations

Amir H. Zargarzadeh1 Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical SciencesIsfahan University of Medical SciencesHezar Jerib AvenueIsfahanIran

Zoha Abdi2 School of Pharmacy and Pharmaceutical SciencesIsfahan University of Medical SciencesIsfahanIran

Sarah Mousavi1 Department of Clinical Pharmacy and Pharmacy Practice, School of Pharmacy and Pharmaceutical SciencesIsfahan University of Medical SciencesHezar Jerib AvenueIsfahanIranCorrespondence[email protected]

Article: 157 | Received 05 Apr 2023, Accepted 20 Nov 2023, Published online: 11 Mar 2024

Cite this article
https://doi.org/10.1186/s40545-023-00672-8
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Iran Covid-19 Statistic. 2023; Available from: https://news.google.com/covid19/map?hl=en-US&mid=%2Fm%2F03shp&gl=US&ceid=US%3Aen.
Google Scholar
Rahmanzade R, et al.Iran's approach to COVID-19: evolving treatment protocols and ongoing clinical trialsFront Public Health20208 10.3389/fpubh.2020.551889 33014984 7498537
PubMed Web of Science ®Google Scholar
Iran’s Diagnostic Therapeutic Flowchart for COVID-19; 1st edition (DTFC1). 2023; Available from: https://irimc.org/Portals/0/NewsAttachment/%20%20%20%20%20%20%20.pdf.
Google Scholar
Iran’s National Campaign Against COVID-19. 2023; Available from: http://treatment.sbmu.ac.ir/uploads/dastoor_basij_meli.pdf.
Google Scholar
Iran’s Diagnostic Therapeutic Flowchart for COVID-19; 9th edition (DTFC9). 2023; Available from: https://salamat.iau.ir/file/download/page/1608614525-19.pdf.
Google Scholar
Rahimi F, Abadi ATBEmergence of the Delta Plus variant of SARS-CoV-2 in IranGene reports202125 1:CAS:528:DC%2BB38XhtlWlurjI 10.1016/j.genrep.2021.101341 34493992 8414840
PubMed Web of Science ®Google Scholar
Sinha S, et al.Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19Nat Med2022281201211 1:CAS:528:DC%2BB3MXisV2lt7rE 10.1038/s41591-021-01576-3 34782790
PubMed Web of Science ®Google Scholar
Organization, W.H., Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. 2020, World Health Organization.
Google Scholar
Zhu Y, et al. Efficacy and safety of remdesivir for Covid-19 treatment: an analysis of randomized, double-blind, placebo-controlled trials. medRxiv. 2020.
Google Scholar
Ammassari A, et al.Comparison of demand for drugs used for COVID-19 treatment and other drugs during the early phase of the COVID-19 pandemic in ItalyJAMA Netw Open202142e2037060e2037060 10.1001/jamanetworkopen.2020.37060 33555328 7871193
PubMed Web of Science ®Google Scholar
Vaduganathan M, et al.Prescription fill patterns for commonly used drugs during the COVID-19 pandemic in the United StatesJAMA20203232425242526 1:CAS:528:DC%2BB3cXhtlSnt7nO 10.1001/jama.2020.9184 32463459 7256862
PubMed Web of Science ®Google Scholar
Belleudi V, et al.Drug prescriptions in the outpatient management of COVID-19: evidence-based recommendations versus real practiceFront Pharmacol202213825479825479 1:CAS:528:DC%2BB38XhtlWjtLzI 10.3389/fphar.2022.825479 35401220 8988061
PubMed Web of Science ®Google Scholar
Fuentes-Gonzalez MF, et al.Outpatient prescription patterns of COVID-19 drugs in the metropolitan area of Mexico CityFam Pract2022393515518 10.1093/fampra/cmab167 34910137
PubMed Web of Science ®Google Scholar
Cheema HA, et al.No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysisJ Infect202286154 10.1016/j.jinf.2022.11.022 36462586
PubMed Web of Science ®Google Scholar
Amadi C, Amadi BFallout following unproven prophylactic use of exogenous vitamin D for COVID-19Science2021104147151
Google Scholar
Abobaker A, Alzwi A, Alraied AHAOverview of the possible role of vitamin C in management of COVID-19Pharmacol Rep202072615171528 1:CAS:528:DC%2BB3cXit1Gqt7rK 10.1007/s43440-020-00176-1 33113146 7592143
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Evaluation of outpatient prescription patterns of COVID-19 drugs in Iran: comparison of real practice with local therapeutic recommendations

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluation of outpatient prescription patterns of COVID-19 drugs in Iran: comparison of real practice with local therapeutic recommendations

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date